AR124242A2 - PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS - Google Patents

PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS

Info

Publication number
AR124242A2
AR124242A2 ARP210103364A ARP210103364A AR124242A2 AR 124242 A2 AR124242 A2 AR 124242A2 AR P210103364 A ARP210103364 A AR P210103364A AR P210103364 A ARP210103364 A AR P210103364A AR 124242 A2 AR124242 A2 AR 124242A2
Authority
AR
Argentina
Prior art keywords
peptides
present
relates
cancers
tumor
Prior art date
Application number
ARP210103364A
Other languages
Spanish (es)
Inventor
Andrea Mahr
Toni Weinschenk
Oliver Schoor
Jens Fritsche
Harpreet Singh
Colette Song
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of AR124242A2 publication Critical patent/AR124242A2/en

Links

Abstract

La presente invención se relaciona con péptidos, proteínas, ácidos nucleicos y células para usar en métodos inmunoterapéuticos. En particular, la presente invención se relaciona con la inmunoterapia de cáncer. La presente invención además se relaciona con epitopes peptídicos de células T asociados a tumor, solos o en combinación con otros péptidos asociados a tumor que por ejemplo pueden servir como ingredientes farmacéuticos activos de composiciones de vacuna que estimulan respuestas inmunológicas antitumorales, a para estimular a células T ex vivo y transferirlas a los pacientes. Los péptidos unidos a las moléculas del complejo mayor de histocompatibilidad (MHC), o los péptidos como tal, también pueden ser blancos de anticuerpos, receptores solubles de células T, y de otras moléculas de unión.The present invention relates to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that, for example, can serve as active pharmaceutical ingredients of vaccine compositions that stimulate antitumor immune responses, to stimulate cells T ex vivo and transfer them to patients. Peptides bound to major histocompatibility complex (MHC) molecules, or peptides themselves, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

ARP210103364A 2015-07-06 2021-12-03 PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS AR124242A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562188870P 2015-07-06 2015-07-06

Publications (1)

Publication Number Publication Date
AR124242A2 true AR124242A2 (en) 2023-03-01

Family

ID=59981555

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP160102025A AR105252A1 (en) 2015-07-06 2016-07-04 PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGIC CANCER AND OTHER CANCER
ARP210103364A AR124242A2 (en) 2015-07-06 2021-12-03 PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
ARP210103365A AR124243A2 (en) 2015-07-06 2021-12-03 PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP160102025A AR105252A1 (en) 2015-07-06 2016-07-04 PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGIC CANCER AND OTHER CANCER

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP210103365A AR124243A2 (en) 2015-07-06 2021-12-03 PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERS

Country Status (1)

Country Link
AR (3) AR105252A1 (en)

Also Published As

Publication number Publication date
AR124243A2 (en) 2023-03-01
AR105252A1 (en) 2017-09-20

Similar Documents

Publication Publication Date Title
CO2017009616A2 (en) Peptides and combination of peptides and scaffolds for immunotherapy against renal cell carcinoma (rcc) and other cancers
AR127119A2 (en) NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
CO2018002202A2 (en) Peptides and combinations of peptides for immunotherapy against prostate cancer and other types of cancer
CL2021000981A1 (en) New peptides and peptide combinations for use in immunotherapy against esophageal and other cancers. (divisional application no. 201703361)
CO2017008902A2 (en) Peptides and new combinations of peptides for immunotherapy against lung cancer, including amicrocytic lung cancer and other types of cancer
CO2018000252A2 (en) Peptides and combinations of peptides for immunotherapy against epithelial ovarian cancer and other types of cancer
CO2018003860A2 (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other types of cancer
PE20181164A1 (en) NEW PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCERS
CO2018010284A2 (en) Treatments against uterine cancer
CO2017012891A2 (en) Peptides and combinations of peptides for immunotherapy against ovarian cancer and other types of cancer
AR103220A1 (en) PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (CHC) AND OTHER TYPES OF CANCER
CO2018000245A2 (en) Peptides and combinations of peptides for immunotherapy against pancreatic cancer and other types of cancer
CR20190388A (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
CR20220115A (en) NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (Div. 2017-522)
CO2018002902A2 (en) Peptides and peptide combinations for the immunotherapeutic treatment of various types of cancer
CR20210167A (en) Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers
CO2018012294A2 (en) Immunotherapy against melanoma and other types of cancer
CL2023001324A1 (en) Peptides, combinations, cells for immunotherapy against bladder cancer and other cancers
CR20190094A (en) Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
CO2018004869A2 (en) Peptides and combination of peptides for immunotherapy against various types of cancer
CO2017009101A2 (en) Peptides and peptide combination
CO2017010830A2 (en) Peptides and combinations of peptides and supports
CO2017003772A2 (en) Peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers
AR124242A2 (en) PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
AR122218A2 (en) PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER